Additional Gadoxetic Acid Enhanced-MRI for Liver Metastases
Not Applicable
- Conditions
- Metastatic liver cancer
- Registration Number
- JPRN-UMIN000015024
- Lead Sponsor
- The University of Tokyo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 450
Inclusion Criteria
Not provided
Exclusion Criteria
1. Cases with another malignancy. 2. Contraindication for contrast media, either CT or MRI.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of metastatic hepatic cancer with gadoxetic acid-enhanced MRI with negative result by contrast-enhanced MDCT.
- Secondary Outcome Measures
Name Time Method Imaging characteristics of metastatic hepatic cancer detected by additional gadoxetic acid-enhanced MR